China Pharma Holdings, Inc. (CPHI)
USD 1.91
(-3.54%)
USD 1.91
(-3.54%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 4.63 Million USD | -47.08% |
| 2022 | 8.75 Million USD | -29.88% |
| 2021 | 12.48 Million USD | 68.12% |
| 2020 | 7.42 Million USD | 63.24% |
| 2019 | 4.55 Million USD | -41.8% |
| 2018 | 7.81 Million USD | -21.28% |
| 2017 | 9.93 Million USD | -11.09% |
| 2016 | 11.16 Million USD | -34.09% |
| 2015 | 16.94 Million USD | -5.43% |
| 2014 | 17.91 Million USD | 3.02% |
| 2013 | 17.39 Million USD | 265.33% |
| 2012 | 4.76 Million USD | 21.09% |
| 2011 | 3.93 Million USD | 3.98% |
| 2010 | 3.78 Million USD | -0.57% |
| 2009 | 3.8 Million USD | 53.32% |
| 2008 | 2.48 Million USD | -7.92% |
| 2007 | 2.69 Million USD | -58.78% |
| 2006 | 6.53 Million USD | 20999.43% |
| 2005 | 30.96 Thousand USD | 0.0% |
| 2004 | - USD | -100.0% |
| 2003 | 765.51 Thousand USD | 53.22% |
| 2002 | 499.61 Thousand USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 1.48 Million USD | -67.9% |
| 2024 Q2 | 4.05 Million USD | 172.72% |
| 2023 Q3 | 5.39 Million USD | -30.76% |
| 2023 Q1 | 8.65 Million USD | -1.21% |
| 2023 Q2 | 7.78 Million USD | -9.96% |
| 2023 FY | 4.63 Million USD | -47.08% |
| 2023 Q4 | 4.63 Million USD | -14.09% |
| 2022 FY | 8.75 Million USD | -29.88% |
| 2022 Q4 | 8.75 Million USD | -13.42% |
| 2022 Q2 | 10.56 Million USD | -11.32% |
| 2022 Q1 | 11.91 Million USD | -4.58% |
| 2022 Q3 | 10.11 Million USD | -4.3% |
| 2021 Q1 | 7.21 Million USD | -2.84% |
| 2021 Q2 | 8 Million USD | 10.98% |
| 2021 Q3 | 7.53 Million USD | -5.89% |
| 2021 Q4 | 12.48 Million USD | 65.68% |
| 2021 FY | 12.48 Million USD | 68.12% |
| 2020 Q3 | 5.04 Million USD | -20.2% |
| 2020 FY | 7.42 Million USD | 63.24% |
| 2020 Q1 | 4.53 Million USD | -0.23% |
| 2020 Q2 | 6.31 Million USD | 39.2% |
| 2020 Q4 | 7.42 Million USD | 47.28% |
| 2019 Q4 | 4.55 Million USD | -6.96% |
| 2019 Q1 | 7.74 Million USD | -0.91% |
| 2019 FY | 4.55 Million USD | -41.8% |
| 2019 Q2 | 7.09 Million USD | -8.47% |
| 2019 Q3 | 4.89 Million USD | -31.02% |
| 2018 Q3 | 8.02 Million USD | -23.82% |
| 2018 Q2 | 10.54 Million USD | -0.37% |
| 2018 FY | 7.81 Million USD | -21.28% |
| 2018 Q1 | 10.57 Million USD | 6.52% |
| 2018 Q4 | 7.81 Million USD | -2.64% |
| 2017 Q2 | 12.75 Million USD | 8.68% |
| 2017 Q1 | 11.73 Million USD | 5.04% |
| 2017 FY | 9.93 Million USD | -11.09% |
| 2017 Q4 | 9.93 Million USD | -5.85% |
| 2017 Q3 | 10.54 Million USD | -17.27% |
| 2016 Q2 | 17.51 Million USD | 4.54% |
| 2016 Q1 | 16.74 Million USD | -1.17% |
| 2016 FY | 11.16 Million USD | -34.09% |
| 2016 Q4 | 11.16 Million USD | -21.42% |
| 2016 Q3 | 14.21 Million USD | -18.82% |
| 2015 FY | 16.94 Million USD | -5.43% |
| 2015 Q4 | 16.94 Million USD | -2.11% |
| 2015 Q3 | 17.31 Million USD | -4.17% |
| 2015 Q2 | 18.06 Million USD | 0.33% |
| 2015 Q1 | 18 Million USD | 0.48% |
| 2014 Q2 | 17.87 Million USD | 0.11% |
| 2014 Q4 | 17.91 Million USD | 0.24% |
| 2014 FY | 17.91 Million USD | 3.02% |
| 2014 Q1 | 17.85 Million USD | 2.63% |
| 2014 Q3 | 17.87 Million USD | 0.03% |
| 2013 Q1 | 4.78 Million USD | 0.55% |
| 2013 Q4 | 17.39 Million USD | 52.48% |
| 2013 FY | 17.39 Million USD | 265.33% |
| 2013 Q3 | 11.4 Million USD | 134.73% |
| 2013 Q2 | 4.85 Million USD | 1.51% |
| 2012 FY | 4.76 Million USD | 21.09% |
| 2012 Q1 | 3.95 Million USD | 0.63% |
| 2012 Q2 | 3.95 Million USD | 0.07% |
| 2012 Q3 | 3.95 Million USD | -0.07% |
| 2012 Q4 | 4.76 Million USD | 20.34% |
| 2011 Q4 | 3.93 Million USD | 0.47% |
| 2011 Q2 | 3.86 Million USD | 1.35% |
| 2011 Q3 | 3.91 Million USD | 1.17% |
| 2011 Q1 | 3.81 Million USD | 0.94% |
| 2011 FY | 3.93 Million USD | 3.98% |
| 2010 Q3 | 2.98 Million USD | -21.81% |
| 2010 Q2 | 3.81 Million USD | 0.4% |
| 2010 Q1 | 3.8 Million USD | 0.02% |
| 2010 FY | 3.78 Million USD | -0.57% |
| 2010 Q4 | 3.78 Million USD | 26.63% |
| 2009 FY | 3.8 Million USD | 53.32% |
| 2009 Q1 | 2.48 Million USD | 0.13% |
| 2009 Q2 | 2.48 Million USD | 0.01% |
| 2009 Q3 | 3.8 Million USD | 53.1% |
| 2009 Q4 | 3.8 Million USD | 0.01% |
| 2008 FY | 2.48 Million USD | -7.92% |
| 2008 Q2 | 2.47 Million USD | 2.19% |
| 2008 Q3 | - USD | -100.0% |
| 2008 Q4 | 2.48 Million USD | 0.0% |
| 2008 Q1 | 2.42 Million USD | -10.12% |
| 2007 Q4 | 2.69 Million USD | -60.36% |
| 2007 FY | 2.69 Million USD | -58.78% |
| 2007 Q3 | 6.79 Million USD | 1.43% |
| 2007 Q2 | 6.69 Million USD | 1.52% |
| 2007 Q1 | 6.59 Million USD | 0.99% |
| 2006 FY | 6.53 Million USD | 20999.43% |
| 2006 Q4 | 6.53 Million USD | 1.27% |
| 2006 Q3 | 6.45 Million USD | 51.59% |
| 2006 Q2 | 4.25 Million USD | 0.36% |
| 2006 Q1 | 4.24 Million USD | 0.0% |
| 2005 Q2 | - USD | 0.0% |
| 2005 Q3 | 6.3 Million USD | 0.0% |
| 2005 Q1 | - USD | 0.0% |
| 2005 FY | 30.96 Thousand USD | 0.0% |
| 2004 Q4 | - USD | 0.0% |
| 2004 FY | - USD | -100.0% |
| 2004 Q1 | - USD | 0.0% |
| 2004 Q2 | 68.4 Thousand USD | 0.0% |
| 2004 Q3 | - USD | -100.0% |
| 2003 Q1 | 796.16 Thousand USD | 4.55% |
| 2003 FY | 765.51 Thousand USD | 53.22% |
| 2003 Q2 | 765.51 Thousand USD | -3.85% |
| 2003 Q4 | - USD | 0.0% |
| 2003 Q3 | - USD | -100.0% |
| 2002 Q1 | 298 Thousand USD | 16.81% |
| 2002 Q2 | 499.61 Thousand USD | 67.65% |
| 2002 Q3 | 497.64 Thousand USD | -0.4% |
| 2002 Q4 | 761.5 Thousand USD | 53.02% |
| 2002 FY | 499.61 Thousand USD | 0.0% |
| 2001 Q4 | 255.11 Thousand USD | 21.5% |
| 2001 Q3 | 209.96 Thousand USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| cbdMD, Inc. | 3.68 Million USD | -25.826% |
| cbdMD, Inc. | 3.68 Million USD | -25.826% |
| Zomedica Corp. | 2.73 Million USD | -69.744% |